L-Carnosine, an Antioxidant and AGE Inhibitor (Advanced Glycation End Products) for Cognitive Enhancement Among Persons With Schizophrenia: A Randomized, Add-on Double-Blind, Placebo Controlled, Clinical Trial
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carnosine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 26 Jan 2013 New trial record
- 16 Jan 2013 Biomarkers information updated